US › Healthcare

Nutex Health Inc (NUTX)

US · Healthcare · Medical Care Facilities

$157.80+3.18%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$216.5M
Revenue YoY
+2.2%
Net profit
$46.8M
Profit YoY
+219.9%
EPS
$5.74
EPS estimate
$5.56
Net margin
21.6%

EPS came in at 5.74 against a street estimate of 5.56 — a beat of 3.2%.

Key statistics

Market cap
$1.01B
P/E
10.8
Forward P/E
0.0
P/B
2.93
Book value
$49.81
EPS (TTM)
$13.67
52-week high
$204.00
52-week low
$77.21
50-day MA
$151.88
200-day MA
$132.94
Beta
1.99

Analyst view

Analysts rate Nutex Health Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $246.40.

Shareholding

Insiders
29.06%
Institutions
42.09%

Largest institutional holders

FundStake
BlackRock Inc5.51%
Pertento Partners LLP5.43%
Vanguard Capital Management, LLC3.18%
American Century Companies Inc2.96%
Topline Capital Management LLC2.58%
State Street Corp1.79%
Geode Capital Management, LLC1.77%
Millennium Management LLC1.30%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Nutex Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.